Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition

Biochimica Et Biophysica Acta
Cord NaujokatCarsten Berges


The highly conserved ubiquitin-proteasome system is the principal machinery for extralysosomal protein degradation in eukaryotic cells. The 26S proteasome, a large multicatalytic multisubunit protease that processes cell proteins by limited and controlled proteolysis, constitutes the central proteolytic component of the ubiquitin-proteasome system. By processing cell proteins essential for development, differentiation, proliferation, cell cycling, apoptosis, gene transcription, signal transduction, senescence, and inflammatory and stress response, the 26S proteasome plays a key role in the regulation and maintenance of basic cellular processes. Various synthetic and biologic inhibitors with different inhibitory profiles towards the proteolytic activities of the 26S proteasome have been identified recently. Such proteasome inhibitors induce apoptosis and cell cycle arrest preferentially in neoplastic cells. Based on these findings proteasome inhibitors became useful in cancer therapy. However, under the pressure of continuous proteasome inhibition, eukaryotic cells can develop complex adaptive mechanisms to subvert the lethal attack of proteasome inhibitors. Such mechanisms include the adaptive modification of the proteasome sys...Continue Reading


Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S W SherwoodR T Schimke
Jun 1, 1996·The Biochemical Journal·A PalmerE Knecht
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·H C Drexler
Apr 3, 1997·Nature·Michael GrollRobert Huber
Mar 1, 1997·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·N TanahashiK Tanaka
Feb 26, 1998·Cell·W BaumeisterE Seemüller
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·Julian AdamsR L Stein
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·L MengC M Crews
Sep 2, 1999·Trends in Biochemical Sciences·Birgitta Tomkinson
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y Xie, A Varshavsky
May 9, 2000·The Journal of Biological Chemistry·N TanahashiK Tanaka
Jun 29, 2000·Annual Review of Biochemistry·D VogesW Baumeister
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·E W WangRickard Glas
Mar 6, 2002·The Journal of Clinical Investigation·Thomas M ZollnerWolf-Henning Boehncke
Mar 28, 2002·Physiological Reviews·Michael H Glickman, Aaron Ciechanover
Oct 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Nicholas MitsiadesKenneth C Anderson
Feb 25, 2003·Nature Immunology·Ulrike SeifertAnne Hosmalin
Oct 3, 2003·Biochemical and Biophysical Research Communications·Cord NaujokatGerhard Opelz
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kai SunWilliam J Murphy
Jun 18, 2004·Cancer Investigation·Julian Adams, Michael Kauffman
Dec 2, 2004·Biochimica Et Biophysica Acta·Dieter H Wolf, Wolfgang Hilt
Dec 2, 2004·Biochimica Et Biophysica Acta·Michael Groll, Robert Huber
Aug 30, 2005·The International Journal of Biochemistry & Cell Biology·Birgitta Tomkinson, Ann-Christin Lindås
Oct 28, 2005·Essays in Biochemistry·Constantine MitsiadesKenneth C Anderson
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·Peter M Voorhees, Robert Z Orlowski
Jan 18, 2006·Annual Review of Medicine·Paul G RichardsonKenneth C Anderson
Feb 16, 2006·European Journal of Immunology·Alessio NencioniAlberto Ballestrero
Jun 21, 2006·Free Radical Biology & Medicine·Silke MeinersKarl Stangl
Mar 22, 2007·International Journal of Cancer. Journal International Du Cancer·Dominika NowisCezary Wójcik


May 30, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Cord Naujokat
Apr 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jérôme ClercMarkus Kaiser
Mar 11, 2011·Cellular and Molecular Life Sciences : CMLS·Peter van Endert
Apr 29, 2009·Cellular and Molecular Life Sciences : CMLS·Erwin KnechtRosana Sáez
Jan 23, 2008·Expert Opinion on Therapeutic Targets·Jörg Votteler, Ulrich Schubert
Jul 10, 2012·Biochemical and Biophysical Research Communications·Sandra EklundBirgitta Tomkinson
Oct 20, 2009·Biochemical and Biophysical Research Communications·Dominik FuchsCord Naujokat
Sep 8, 2009·Journal of Cellular Biochemistry·Carsten BergesCord Naujokat
Sep 12, 2009·Chembiochem : a European Journal of Chemical Biology·Jérôme ClercMarkus Kaiser
Mar 8, 2008·Hematological Oncology·Scott Marshall McCloskeyAlexandra E Irvine
Apr 9, 2010·European Journal of Haematology·Jan SterzIvana von Metzler
Mar 29, 2014·Angewandte Chemie·Takuya ChibaSatoshi Ichikawa
Aug 22, 2009·European Journal of Pain : EJP·Cristina MeregalliGuido Cavaletti
Mar 4, 2014·Medicinal Research Reviews·Nicola MicaleMaria Zappalà
Jan 9, 2013·Methods : a Companion to Methods in Enzymology·Shelly RozenMichal Sharon
Nov 1, 2011·Chemical Communications : Chem Comm·Melissa Ann Gräwert, Michael Groll
Jan 7, 2016·Annual Review of Immunology·Michael LenardoCarrie L Lucas
Jun 14, 2019·Stem Cells International·Bertal H AktasSüleyman Ergün

Related Concepts

Malignant Neoplasms
Apoptosis, Intrinsic Pathway
Ubiquitin, Human
Proteasome inhibitor

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.